The Board of Directors of Novozymes appoints Peder Holk Nielsen as President
and Chief Executive Officer with effect from April 1, 2013 

The Board of Directors of Novozymes has appointed Peder Holk Nielsen as
President and Chief Executive Officer with effect from April 1, 2013. Mr.
Nielsen will replace the current President and CEO Steen Riisgaard who after 12
years as CEO and 33 years in Novozymes and Novo Industri/Novo Nordisk steps
down according to plan. 



Mr. Nielsen, 56, is currently serving as Executive Vice President and Head of
Enzyme Business, a position he has held since 2007. Mr. Nielsen’s career spans
management positions in Novozymes and Novo Industri/Novo Nordisk across
business development, R&D, quality management and sales & marketing. He holds a
M.Sc. and Ph.D. in Chemical Engineering from the Technical University of
Denmark, and a B.Com. in International Business Management from the Copenhagen
Business School. 



Andrew Fordyce will join the executive leadership team on April 1, 2013

From April 1, 2013 Novozymes will have a new executive leadership team. All
Executive Vice Presidents of the current executive management team will
continue and Andrew Fordyce, 49, will join them.  Mr. Fordyce is currently Vice
President, Sales and Customer Solutions. Since joining the company in 1993, he
has held several positions in commercial operations, R&D and production in
Denmark, Switzerland and the US. Mr. Fordyce holds a Ph.D. in Chemical
Engineering from the University of Texas at Austin. 

On April 1, 2013 the executive leadership team will have the following members
with new areas of responsibility: 



President & CEO Peder Holk Nielsen

Business Development: EVP Thomas Videbæk

Business Operations: EVP Andrew Fordyce

Supply Operations: EVP Thomas Nagy

Research & Development: EVP and CSO Per Falholt

Corporate Functions: EVP and CFO Benny D. Loft





Contact persons:      Investor Relations:   
Press and media:                            
René Tronborg (DK)    Maarit Pokkinen (DK)  
Tel.: +45 3077 2274   Tel.: +45 3077 8682   
Paige Donnelly (USA)  Martin Riise (DK)     
Tel.: +1 919 2184501  Tel.: +45 3077 0738   
                      Thomas Bomhoff (USA), 
                      Tel.: +1 919 6492565  
                      DK Tel.: +45 3077 1226